North of the Border: Overview of Biologics and Biosimilars in Canada

• Overview of Canada’s Regulatory and Intellectual Property Regimes as they apply to Biologics and Biosimilars

• The Regulatory Pathway for Marketing Approval, Data Protection, Patent Linkage and Litigation, and Current Biosimilar Approvals and Applications 

• A Comparison to the US and European Regimes: Differences and Similarities with Canada

Urszula Wojtyra, IP Lawyer and Partner, Smart & Biggar
David Schwartz, Partner, Smart & Biggar